Severe Anemia from Multiple Gastric Hyperplastic Polyps in a Hemodialysis Patient after Long-term Use of a Proton-pump Inhibitor

被引：1
|
作者：
Ikeda, Shiyo [1 ,2 ]
Takahashi, Toshiya [1 ,2 ]
Tandoh, Toshitsugu [3 ]
Ushiyama, Kaori [2 ,4 ]
Kida, Yujiro [1 ,2 ]
机构：
[1] Takashimadaira Chuo Gen Hosp, Dept Nephrol, Tokyo, Japan
[2] Takashimadaira Chuo Gen Hosp, Blood Purificat Ctr, Tokyo, Japan
[3] Takashimadaira Chuo Gen Hosp, Dept Clin Engn, Tokyo, Japan
[4] Takashimadaira Chuo Gen Hosp, Dept Nursing, Tokyo, Japan
来源：
INTERNAL MEDICINE | 2024年 / 63卷 / 05期
关键词：
hemodialysis; severe anemia; gastric bleeding; gastric hyperplastic polyp; proton-pump inhibitor; gastrin; CHRONIC KIDNEY-DISEASE; HELICOBACTER-PYLORI; SERUM GASTRIN; ACID SECRETION; RISK-FACTORS; THERAPY; DISAPPEARANCE; DISCONTINUATION; MANAGEMENT; JAPANESE;
D O I：
10.2169/internalmedicine.2091-23
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 90-year-old man on maintenance hemodialysis was admitted due to severe symptomatic anemia. Biopsies under esophagogastroduodenoscopy demonstrated that the cause of anemia was intermittent blood oozing from multiple gastric hyperplastic polyps. Even after successful eradication of Helicobacter pylori, he showed hypergastrinemia (480 pg/mL) owing to esomeprazole (proton-pump inhibitor) therapy for the past 4.5 years to treat reflux esophagitis. Seven months after we switched esomeprazole to famotidine (H2-receptor antagonist), those gastric polyps and anemia were remarkably ameliorated with lowered gastrin levels. This case indicates that long-term use of a proton-pump inhibitor triggers chronic hypergastrinemia, leading to gastric hyperplastic polyps and subsequent severe anemia.
引用
收藏
页码：649 / 657
页数：9
相关论文
共 50 条
  • [21] Multiple metachronous foveolar-type gastric adenomas in a Helicobacter pylori-naïve patient with long-term use of a proton pump inhibitor: a case report
    Miyaoka, Yoichi
    Shibagaki, Kotaro
    Kushima, Ryoji
    Omachi, Taisuke
    Hino, Takanobu
    Fujiwara, Aya
    Tsukano, Kousuke
    Ogawa, Sayaka
    Yamanouchi, Satoshi
    Tanaka, Masaki
    Miyake, Tatsuya
    Fujishiro, Hirofumi
    Kohge, Naruaki
    Ohnuma, Hideyuki
    Ishimura, Norihisa
    Mishiro, Tsuyoshi
    Ishihara, Shunji
    GASTRIC CANCER, 2025, : 537 - 543
  • [22] The Risk of Epilepsy after Long-term Proton Pump Inhibitor Therapy
    Liang, Chih-Sung
    Bai, Ya-Mei
    Hsu, Ju-Wei
    Huang, Kai-Lin
    Ko, Nai-Ying
    Tsai, Chia-Kuang
    Yeh, Ta-Chuan
    Chu, Hsuan-Te
    Tsai, Shih-Jen
    Chen, Tzeng-Ji
    Chen, Mu-Hong
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2021, 87 : 88 - 93
  • [23] Influence of hypergastrinemia secondary to long-term proton pump inhibitor treatment on ECL cell tumorigenesis in human gastric mucosa
    Tatsuguchi, Atsushi
    Hoshino, Shintaro
    Kawami, Noriyuki
    Gudis, Katya
    Nomura, Tsutomu
    Shimizu, Akira
    Iwakiri, Katsuhiko
    PATHOLOGY RESEARCH AND PRACTICE, 2020, 216 (10)
  • [24] Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study
    Losurdo, Giuseppe
    Caccavo, Natale Lino Bruno
    Indellicati, Giuseppe
    Celiberto, Francesca
    Ierardi, Enzo
    Barone, Michele
    Di Leo, Alfredo
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (08)
  • [25] Long-term proton pump inhibitor administration, H pylori and gastric cancer: lessons from the gerbil
    Fox, James G.
    Kuipers, Ernst J.
    GUT, 2011, 60 (05) : 567 - 568
  • [26] Long-Term Proton Pump Inhibitor Use in Children: A Retrospective Review of Safety
    V. Tolia
    K. Boyer
    Digestive Diseases and Sciences, 2008, 53 : 385 - 393
  • [27] Long-term proton pump inhibitor use in children: A retrospective review of safety
    Tolia, V.
    Boyer, K.
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (02) : 385 - 393
  • [28] Rebound Acid Hypersecretion after Withdrawal of Long-Term Proton Pump Inhibitor (PPI) Treatment-Are PPIs Addictive?
    Namikawa, Ken
    Bjornsson, Einar Stefan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (10)
  • [29] Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury
    Yutaka Hatakeyama
    Taro Horino
    Tatsuki Matsumoto
    Yoshio Terada
    Yoshiyasu Okuhara
    Clinical and Experimental Nephrology, 2021, 25 : 1087 - 1092
  • [30] Long-Term Proton Pump Inhibitor Use Is Not Associated With Changes in Bone Strength and Structure
    Targownik, Laura E.
    Goertzen, Andrew L.
    Luo, Yunhua
    Leslie, William D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (01): : 95 - 101
12345